Are you Dr. Balk?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 27 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
330 Brookline Ave
Boston, MA 02215Phone+1 617-667-5288- Is this information wrong?
Summary
- Dr. Steven Balk, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Beth Israel Deaconess Medical Center and is a Professor of Medicine at Beth Israel Deaconess Medical Center.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1989
Harvard Medical SchoolClass of 1983
Certifications & Licensure
MA State Medical License 1985 - 2025- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1996
Clinical Trials
- In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer Start of enrollment: 2008 Feb 01
- Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer Start of enrollment: 2005 Feb 01
Publications & Presentations
PubMed
- A carboxy-terminal ubiquitylation site regulates androgen receptor activity.Arai, S., Gao, Y., Yu, Z., Xie, L., Wang, L., Zhang, T., Nouri, M., Chen, S., Asara, J., Balk, S.> ;Communications Biology. 2024 Jan 5
- Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression.Anna Besschetnova, Wanting Han, Mingyu Liu, Yanfei Gao, Muqing Li, Zifeng Wang, Maryam Labaf, Susan Patalano, Kavita Venkataramani, Rachel E Muriph, Jill A Macoska, Ke...> ;Cancer Research Communications. 2023 Aug 1
- 8 citationsLSD1 Inhibition Disrupts Super-Enhancer-Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer.Muqing Li, Mingyu Liu, Wanting Han, Zifeng Wang, Dong Han, Susan Patalano, Jill A Macoska, Steven P Balk, Housheng Hansen He, Eva Corey, Shuai Gao, Changmeng Cai> ;Cancer Research. 2023 May 15
- Join now to see all
Press Mentions
Thank You for Your PatientsMarch 23rd, 2020
The Prostate Cancer Foundation Awards $5.5 Million to PCF Challenge Award Recipients to Advance Prostate Cancer ResearchOctober 30th, 2018
Grant Support
- Training Grant In Cancer BiologyNational Cancer Institute2007–2011
- Targeting Ar-Ncor Interaction In Prostate CancerNational Cancer Institute2007–2011
- HTS For Androgen Receptor Antagonists That Recruit NcorNational Institute Of Neurological Disorders And Stroke2006
- AR Transgene Model Of Prostate Intraepithelial NeoplasiaNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
- Immune Regulation By CD1D Reactive NKR-P1 T CellsNational Institute Of Allergy And Infectious Diseases1999–2003
- Androgen Receptor In Hormone Refractory DiseaseNational Cancer Institute2002
- Invariant NKT Cells For Phase 1 Cancer TrialsNational Cancer Institute2001–2002
- Function Of Human Intestinal Intraepithelial LymphocytesNational Institute Of Allergy And Infectious Diseases1993–2001
- AR Mutations In Androgen-Independent Prostate CancerNational Cancer Institute1996–1999
- Immune Regulation By CD1D Reactive Nkp-P1 T CellsNational Institute Of Allergy And Infectious Diseases1998
- Isolation Of A Human Homologue Of The Murine LY-6 SystemNational Cancer Institute1989
- Isolation Of A Human Homologue Of The Murine LY-6 SystemNational Cancer Institute1987–1988
Hospital Affiliations
Beth Israel Deaconess Medical CenterBoston, Massachusetts
